Citadel Advisors
TSVT

Citadel Advisors’s 2seventy bio TSVT Stock Holding History

Citadel Advisors’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-23,800
Closed -$118K – 15154
2025
Q1 		$118K Buy
23,800
+6,500
+38% +$20.7K ﹤0.01% 11239
2024
Q4 		$50.9K Sell
17,300
-23,100
-57% -$94.7K ﹤0.01% 12374
2024
Q3 		$191K Buy
40,400
+29,300
+264% +$132K ﹤0.01% 10224
2024
Q2 		$42.7K Sell
11,100
-29,300
-73% -$132K ﹤0.01% 11938
2024
Q1 		$216K Buy
40,400
+35,888
+795% +$169K ﹤0.01% 10152
2023
Q4 		$19.3K Sell
4,512
-2,735
-38% -$8.41K ﹤0.01% 12648
2023
Q3 		$28.4K Sell
7,247
-13,500
-65% -$88.5K ﹤0.01% 12320
2023
Q2 		$210K Sell
20,747
-2,400
-10% -$25.4K ﹤0.01% 9776
2023
Q1 		$236K Sell
23,147
-26,331
-53% -$301K ﹤0.01% 9871
2022
Q4 		$464K Buy
49,478
+3,644
+8% +$51.4K ﹤0.01% 8398
2022
Q3 		$667K Buy
45,834
+17,289
+61% +$257K ﹤0.01% 7846
2022
Q2 		$377K Buy
28,545
+5,412
+23% +$73.7K ﹤0.01% 9276
2022
Q1 		$395K Sell
23,133
-27,159
-54% -$461K ﹤0.01% 9937
2021
Q4 		$1.29M Buy
+50,292
New +$1.57M ﹤0.01% 7279

Other funds holding TSVT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Citadel Advisors's TSVT Position: Q1 2025 in Review

Citadel Advisors sold out of 2seventy bio (TSVT) in Q1 2025, closing a stake of 12,318 shares — an estimated $39.1K sold.

Citadel Advisors first reported a position in TSVT in Q2 2022 and held it in 11 quarters. The position peaked at $24.1M in Q1 2023. 139 funds tracked by Wall St. Rank hold TSVT as of Q1 2025.

  • Citadel Advisors reported no remaining 2seventy bio position as of Q1 2025 after selling out during the quarter.
  • Citadel Advisors sold 12,318 2seventy bio shares in Q1 2025, an estimated $39.1K.
  • Citadel Advisors first reported a position in 2seventy bio in Q2 2022 and held it in 11 quarters.
  • Citadel Advisors's 2seventy bio position peaked at $24.1M in Q1 2023.
  • 139 funds tracked by Wall St. Rank held 2seventy bio as of Q1 2025.

Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.